621 filings
Page 15 of 32
PRE 14A
NBSE
NeuBase Therapeutics Inc
7 Dec 18
Preliminary proxy
4:07pm
8-K
NBSE
NeuBase Therapeutics Inc
4 Oct 18
Submission of Matters to a Vote of Security Holders
8:00am
DEF 14A
NBSE
NeuBase Therapeutics Inc
Definitive proxy
7 Sep 18
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
29 Aug 18
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
23 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
10-Q
2018 Q3
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 Aug 18
5:07pm
8-K
NBSE
NeuBase Therapeutics Inc
14 Aug 18
Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results
12:00am
10-Q
2018 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
15 May 18
5:27pm
8-K
NBSE
NeuBase Therapeutics Inc
15 May 18
Ohr Pharmaceutical Reports Fiscal Second Quarter 2018 Financial Results
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
23 Feb 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
Hirschman Orin
15 Feb 18
Ohr Pharmaceutical Inc
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
14 Feb 18
Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results
12:00am
10-Q
2018 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 Feb 18
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
5 Jan 18
Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
15 Dec 17
Other Events
12:00am
10-K
2017 FY
NBSE
NeuBase Therapeutics Inc
Annual report
15 Dec 17
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
15 Dec 17
Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results
12:00am
4/A
NBSE
NeuBase Therapeutics Inc
6 Dec 17
Ohr Pharmaceutical / ORIN HIRSCHMAN ownership change
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
20 Oct 17
Departure of Directors or Certain Officers
12:00am
4
June Sherie Almenoff
18 Oct 17
Ohr Pharmaceutical / June Sherie Almenoff ownership change
12:00am